HHV-8 positive clinically advanced castrate-resistant prostate cancer (mCRPC): A potentially distinct molecular subset.
Source: Getty Images Biopsy Gleason patterns 4+5, 5+4, and 5+5 should be given separate consideration in pretreatment risk stratification, according to investigators. Prostate cancer (PCa) survival ...